Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) su...
FDA Recall #D-0560-2025 — Class II — July 18, 2025
Product Description
Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Reason for Recall
Lack of Processing Controls.
Recalling Firm
AEQUITA PHARMACY — Kirkland, WA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
155 vials
Distribution
MA
Code Information
All Lots within expiry.
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated